These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6402584)

  • 1. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats II: mechanism of absorption enhancement with organic acids.
    Okada H; Yamazaki I; Yashiki T; Mima H
    J Pharm Sci; 1983 Jan; 72(1):75-8. PubMed ID: 6402584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement.
    Okada H; Yamazaki I; Ogawa Y; Hirai S; Yashiki T; Mima H
    J Pharm Sci; 1982 Dec; 71(12):1367-71. PubMed ID: 6818337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats III: Effect of estrous cycle on vaginal absorption of hydrophilic model compounds.
    Okada H; Yashiki T; Mima H
    J Pharm Sci; 1983 Feb; 72(2):173-6. PubMed ID: 6403693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats. IV: Evaluation of the vaginal absorption and gonadotropin responses by radioimmunoassay.
    Okada H; Yamazaki I; Yashiki T; Shimamoto T; Mima H
    J Pharm Sci; 1984 Mar; 73(3):298-302. PubMed ID: 6425491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization of gonadotropin-releasing response following vaginal consecutive administration of leuprolide in rats.
    Okada H; Yamazaki I; Sakura Y; Yashiki T; Shimamoto T; Mima H
    J Pharmacobiodyn; 1983 Jul; 6(7):512-22. PubMed ID: 6417315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of rat mammary tumors by a potent luteinizing hormone-releasing hormone analogue (leuprolide) administered vaginally.
    Okada H; Sakura Y; Kawaji H; Yashiki T; Mima H
    Cancer Res; 1983 Apr; 43(4):1869-74. PubMed ID: 6403230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced absorption of bumetanide from suppositories containing weak acids in rabbits.
    Yagi N; Kenmotsu H; Shimode Y; Oda K; Sekikawa H; Takada M
    Biol Pharm Bull; 1993 Mar; 16(3):263-7. PubMed ID: 8364470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.
    Okada H; Inoue Y; Heya T; Ueno H; Ogawa Y; Toguchi H
    Pharm Res; 1991 Jun; 8(6):787-91. PubMed ID: 1905810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.
    Okada H; Heya T; Ogawa Y; Shimamoto T
    J Pharmacol Exp Ther; 1988 Feb; 244(2):744-50. PubMed ID: 3126294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New hydrophilic vehicle enabling rectal and vaginal absorption of insulin, heparin, phenol red and gentamicin.
    Touitou E; Donbrow M; Azaz E
    J Pharm Pharmacol; 1978 Oct; 30(10):662-3. PubMed ID: 30828
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of testosterone production with ketoconazole alone and in combination with a gonadotropin releasing hormone analogue in the rat.
    English HF; Santner SJ; Levine HB; Santen RJ
    Cancer Res; 1986 Jan; 46(1):38-42. PubMed ID: 3079588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis.
    Sakata M; Terakawa N; Mizutani T; Tanizawa O; Matsumoto K; Terada N; Sudo K
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1679-84. PubMed ID: 2122726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined impact of pH and organic acids on iron uptake by Caco-2 cells.
    Salovaara S; Sandberg AS; Andlid T
    J Agric Food Chem; 2003 Dec; 51(26):7820-4. PubMed ID: 14664552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogue.
    Trachtenberg J
    J Urol; 1983 Jun; 129(6):1149-52. PubMed ID: 6406688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokinetics.
    Haviy F; Fitzpatrick TD; Nichols CJ; Swenson RE; Bush EN; Diaz G; Nguyen A; Nellans HN; Hoffman DJ; Ghanbari H
    J Med Chem; 1992 Oct; 35(21):3890-4. PubMed ID: 1433199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to administration of peptides in women: Systemic absorption of a GnRH agonist via transvaginal ring delivery system.
    Kimball AB; Javorsky E; Ron ES; Crowley W; Langer R
    J Control Release; 2016 Jul; 233():19-28. PubMed ID: 27130696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravaginal instillation of gonadotropin-releasing hormone analogues with an absorption enhancer induced a surge of luteinizing hormone in lactating dairy cows.
    Wijma R; Stangaferro ML; Masello M; Elmetwally MA; Granados GE; Amovilli F; Giordano JO
    J Dairy Sci; 2017 Sep; 100(9):7626-7637. PubMed ID: 28711266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of formulation adjuvants on gastrointestinal absorption of leuprolide acetate.
    Adjei A; Love S; Johnson E; Diaz G; Greer J; Haviv F; Bush E
    J Drug Target; 1993; 1(3):251-8. PubMed ID: 8069567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers.
    Adjei A; Garren J
    Pharm Res; 1990 Jun; 7(6):565-9. PubMed ID: 2114618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term suppression of luteinizing hormone, follicle-stimulating hormone and testosterone by daily administration of leuprolide.
    Glode LM; Smith JA
    J Urol; 1987 Jan; 137(1):57-60. PubMed ID: 3098990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.